Visalytics
Visalytics
approved EB-2 (NIW)

Research Associate

Bioinformatics · Italy · 2024-01-10

Processing Time
5 days
Decision Date
2024-01-10
Location
Massachusetts
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner intends to develop computational tools and infrastructure for analyzing germline and somatic mutations to advance genomic research. His work focuses on facilitating the integration of these tools into clinical practice to enhance the diagnosis and treatment of genetic diseases and cancers. This includes providing open-source, cloud-based solutions for WES/WGS data analysis to simplify genomics data access.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research on genomic mutations and clinical integration for cancer treatment was found to have significant intrinsic value and national scope.

2 Well-positioned to Advance the Endeavor Met

The petitioner's Ph.D., publication record, and high citation count (495) demonstrated his expertise and influence in the field.

3 Waiver of Job Offer and Labor Certification Met

On balance, the U.S. benefits from waiving the labor certification due to the petitioner's contributions to healthcare and genomic diagnostics.

Why This Petition Was Approved

The petition was approved based on the petitioner's Ph.D. in molecular medicine and a strong record of 8 peer-reviewed journal articles with 495 citations. Evidence included funding from the NIH and the Bill and Melinda Gates Foundation, as well as participation in peer review for Scientific Reports. The case successfully satisfied all three Dhanasar prongs by demonstrating the national importance of advancing genomic diagnostics.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Grants
Original Contributions
Judging Experience
Government Alignment

Similar Cases

Analyst

Biotechnology · India

WeGreened EB-2 (NIW) approved
Maryland 156 days 2025-02-01
The petitioner proposes to continue research utilizing advanced computing and bioinformatic techniques to process and analyze multi-omics data. This work aims to further the understanding of genetic mutations and their effects on organismal biology for applications in cancer research, biomedical sciences, biodiversity conservation, and agricultural sciences.
View Case

Others

Biotechnology · Iran

WeGreened EB-2 (NIW) approved
Illinois 567 days 2025-06-11
The petitioner proposes to develop advanced computational pipelines and machine learning algorithms for genomic data analysis. This work focuses on enhancing treatments for infectious diseases, cancer, diabetes, and reproductive health by improving the molecular understanding of disease pathology. The endeavor aims to advance personalized medicine and improve health outcomes across the United States.
View Case

Research Assistant

Biotechnology · China

WeGreened EB-2 (NIW) rfe approved
Texas 30 days 2025-06-20
The petitioner proposes to elucidate the molecular mechanisms connecting genetic variation to complex disease outcomes using RNA sequencing, whole genome sequencing, and proteomics. This work aims to support the advancement of precision medicine through the development of accurate diagnostics and tailored therapies for various disorders.
View Case

Research Scientist

Information Technology · India

WeGreened EB-2 (NIW) approved
Texas 46 days 2025-06-09
The petitioner proposes to develop advanced computational algorithms to analyze genomic data for identifying mutations and variants that drive cancer progression. This work involves prioritizing and validating cancer driver genes and integrating these findings into clinical workflows to improve diagnosis accuracy and prognosis. The goal is to support personalized treatment strategies and reduce the impact of cancer on patients and the U.S. healthcare system.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from Italy

Case data sourced from publicly available petition decisions and case studies. Decision date: 2024-01-10.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 5 days
Criteria Met 3 / 3
Evidence Types 6

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,816
Success Rate 53.6%
Sustained 2,046
Dismissed 1,674

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Italy All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist